Mutation Analysis of MR-1, SLC2A1, and CLCN1 in 28 PRRT2-negative Paroxysmal Kinesigenic Dyskinesia Patients
Background: Paroxysmal kinesigenic dyskinesia (PKD) is the most common subtype of paroxysmal dyskinesias and is caused by mutations in PRRT2 gene. The majority of familial PKD was identified to harbor PRRT2 mutations. However, over two-third of sporadic PKD patients did not carry anyPRRT2 mutation,...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2016-01-01
|
| Series: | Chinese Medical Journal |
| Subjects: | |
| Online Access: | http://www.cmj.org/article.asp?issn=0366-6999;year=2016;volume=129;issue=9;spage=1017;epage=1021;aulast=Wang |
| _version_ | 1819291241778511872 |
|---|---|
| author | Hong-Xia Wang Hong-Fu Li Gong-Lu Liu Xiao-Dan Wen Zhi-Ying Wu |
| author_facet | Hong-Xia Wang Hong-Fu Li Gong-Lu Liu Xiao-Dan Wen Zhi-Ying Wu |
| author_sort | Hong-Xia Wang |
| collection | DOAJ |
| description | Background: Paroxysmal kinesigenic dyskinesia (PKD) is the most common subtype of paroxysmal dyskinesias and is caused by mutations in PRRT2 gene. The majority of familial PKD was identified to harbor PRRT2 mutations. However, over two-third of sporadic PKD patients did not carry anyPRRT2 mutation, suggesting an existence of additional genetic mutations or possible misdiagnosis due to clinical overlap.
Methods: A cohort of 28 Chinese patients clinically diagnosed with sporadic PKD and excluded PRRT2 mutations were recruited. Clinical features were evaluated, and all subjects were screened for MR-1, SLC2A1, and CLCN1 genes, which are the causative genes of paroxysmal nonkinesigenic dyskinesia (PNKD), paroxysmal exertion-induced dyskinesia, and myotonia congenita (MC), respectively. In addition, 200 genetically matched healthy individuals were recruited as controls.
Results: A total of 16 genetic variants including 4 in MR-1 gene, 8 in SLC2A1 gene, and 4 in CLCN1 gene were detected. Among them, SLC2A1 c.363G>A mutation was detected in one case, and CLCN1 c.1205C>T mutation was detected in other two cases. Neither of them was found in 200 controls as well as 1000 Genomes database and ExAC database. Both mutations were predicted to be pathogenic by SIFT and PolyPhen2. The SLC2A1 c.363G>A mutation was novel.
Conclusions: The phenotypic overlap may lead to the difficulty in distinguishing PKD from PNKD and MC. For those PRRT2- negative PKD cases, screening of SLC2A1 and CLCN1 genes are useful in confirming the diagnosis. |
| first_indexed | 2024-12-24T03:35:31Z |
| format | Article |
| id | doaj.art-488822fc8dae4d869d710cc419199b48 |
| institution | Directory Open Access Journal |
| issn | 0366-6999 |
| language | English |
| last_indexed | 2024-12-24T03:35:31Z |
| publishDate | 2016-01-01 |
| publisher | Wolters Kluwer |
| record_format | Article |
| series | Chinese Medical Journal |
| spelling | doaj.art-488822fc8dae4d869d710cc419199b482022-12-21T17:17:05ZengWolters KluwerChinese Medical Journal0366-69992016-01-0112991017102110.4103/0366-6999.180529Mutation Analysis of MR-1, SLC2A1, and CLCN1 in 28 PRRT2-negative Paroxysmal Kinesigenic Dyskinesia PatientsHong-Xia WangHong-Fu LiGong-Lu LiuXiao-Dan WenZhi-Ying WuBackground: Paroxysmal kinesigenic dyskinesia (PKD) is the most common subtype of paroxysmal dyskinesias and is caused by mutations in PRRT2 gene. The majority of familial PKD was identified to harbor PRRT2 mutations. However, over two-third of sporadic PKD patients did not carry anyPRRT2 mutation, suggesting an existence of additional genetic mutations or possible misdiagnosis due to clinical overlap. Methods: A cohort of 28 Chinese patients clinically diagnosed with sporadic PKD and excluded PRRT2 mutations were recruited. Clinical features were evaluated, and all subjects were screened for MR-1, SLC2A1, and CLCN1 genes, which are the causative genes of paroxysmal nonkinesigenic dyskinesia (PNKD), paroxysmal exertion-induced dyskinesia, and myotonia congenita (MC), respectively. In addition, 200 genetically matched healthy individuals were recruited as controls. Results: A total of 16 genetic variants including 4 in MR-1 gene, 8 in SLC2A1 gene, and 4 in CLCN1 gene were detected. Among them, SLC2A1 c.363G>A mutation was detected in one case, and CLCN1 c.1205C>T mutation was detected in other two cases. Neither of them was found in 200 controls as well as 1000 Genomes database and ExAC database. Both mutations were predicted to be pathogenic by SIFT and PolyPhen2. The SLC2A1 c.363G>A mutation was novel. Conclusions: The phenotypic overlap may lead to the difficulty in distinguishing PKD from PNKD and MC. For those PRRT2- negative PKD cases, screening of SLC2A1 and CLCN1 genes are useful in confirming the diagnosis.http://www.cmj.org/article.asp?issn=0366-6999;year=2016;volume=129;issue=9;spage=1017;epage=1021;aulast=WangCLCN1; MR-1;Paroxysmal Kinesigenic Dyskinesia; PRRT2; SLC2A1 |
| spellingShingle | Hong-Xia Wang Hong-Fu Li Gong-Lu Liu Xiao-Dan Wen Zhi-Ying Wu Mutation Analysis of MR-1, SLC2A1, and CLCN1 in 28 PRRT2-negative Paroxysmal Kinesigenic Dyskinesia Patients Chinese Medical Journal CLCN1; MR-1;Paroxysmal Kinesigenic Dyskinesia; PRRT2; SLC2A1 |
| title | Mutation Analysis of MR-1, SLC2A1, and CLCN1 in 28 PRRT2-negative Paroxysmal Kinesigenic Dyskinesia Patients |
| title_full | Mutation Analysis of MR-1, SLC2A1, and CLCN1 in 28 PRRT2-negative Paroxysmal Kinesigenic Dyskinesia Patients |
| title_fullStr | Mutation Analysis of MR-1, SLC2A1, and CLCN1 in 28 PRRT2-negative Paroxysmal Kinesigenic Dyskinesia Patients |
| title_full_unstemmed | Mutation Analysis of MR-1, SLC2A1, and CLCN1 in 28 PRRT2-negative Paroxysmal Kinesigenic Dyskinesia Patients |
| title_short | Mutation Analysis of MR-1, SLC2A1, and CLCN1 in 28 PRRT2-negative Paroxysmal Kinesigenic Dyskinesia Patients |
| title_sort | mutation analysis of mr 1 slc2a1 and clcn1 in 28 prrt2 negative paroxysmal kinesigenic dyskinesia patients |
| topic | CLCN1; MR-1;Paroxysmal Kinesigenic Dyskinesia; PRRT2; SLC2A1 |
| url | http://www.cmj.org/article.asp?issn=0366-6999;year=2016;volume=129;issue=9;spage=1017;epage=1021;aulast=Wang |
| work_keys_str_mv | AT hongxiawang mutationanalysisofmr1slc2a1andclcn1in28prrt2negativeparoxysmalkinesigenicdyskinesiapatients AT hongfuli mutationanalysisofmr1slc2a1andclcn1in28prrt2negativeparoxysmalkinesigenicdyskinesiapatients AT gongluliu mutationanalysisofmr1slc2a1andclcn1in28prrt2negativeparoxysmalkinesigenicdyskinesiapatients AT xiaodanwen mutationanalysisofmr1slc2a1andclcn1in28prrt2negativeparoxysmalkinesigenicdyskinesiapatients AT zhiyingwu mutationanalysisofmr1slc2a1andclcn1in28prrt2negativeparoxysmalkinesigenicdyskinesiapatients |